Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
Despite this global progress, over 50 million infants still do not have access to a rotavirus vaccine. Barriers include cost, reduced vaccine efficacy in low‑income settings, and ongoing safety concerns. To address these challenges, the oral RV3‑BB rotavirus vaccine was developed at MCRI with
VIRGo conducted vaccine and immunisation research with clinical trials of new vaccines, and epidemiologic studies of vaccine-preventable disease. Our findings enable us to advise policymakers on the optimal use of vaccines in national immunisation schedules, in pandemic influenza preparedness and
Our group facilitates high-quality medical imaging research on the Melbourne Children’s campus. We aim to improve our knowledge of childhood development and health through the use of sophisticated imaging acquisition and analysis techniques.
This CRE has been archived. This CRE was funded by the NHMRC and Telematics Trust between 2012 - 2018. We used the latest approaches in molecular genetics, neuro-imaging, epidemiology, biostatistics and health economics to investigate factors that affect and improve child language and
To enhance the understanding of how an injury to a child’s brain can impact cognitive, behavioural, and social development.
Speech and language disorders can make it difficult for children to speak, read and write. As many as one in five preschool children experience language and speech disorders, such as stuttering or childhood apraxia of speech (CAS). Some children grow out of their speaking disorder, but others go on
Genetic screening involves testing certain populations to detect signs of disease or risk factors for the development of future health problems.
The ID MAGIC Trial aims to find a better way of treating children with cytomegalovirus (CMV) infection, by seeing if giving ganciclovir as a personalised dose using a web-based dosing app is better than the current method based only on the child’s weight.
Our research provides evidence for policy and clinical practice to improve child health outcomes in resource-poor settings in the Asia-Pacific region.
Page 97 of 100
